Walgreens Boots Alliance (NASDAQ:WBA) PT Lowered to $19.00 at Barclays

Walgreens Boots Alliance (NASDAQ:WBA) had its price objective decreased by Barclays from $21.00 to $19.00 in a report released on Monday, Benzinga reports. Barclays currently has an underweight rating on the pharmacy operator’s stock.

A number of other research firms have also issued reports on WBA. Deutsche Bank Aktiengesellschaft lowered their target price on Walgreens Boots Alliance from $23.00 to $22.00 and set a hold rating on the stock in a report on Wednesday, April 3rd. Truist Financial reaffirmed a hold rating and issued a $25.00 target price on shares of Walgreens Boots Alliance in a report on Monday, April 1st. Morgan Stanley decreased their price objective on Walgreens Boots Alliance from $16.00 to $13.00 and set an underweight rating on the stock in a report on Friday, May 31st. UBS Group decreased their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a neutral rating on the stock in a report on Wednesday, April 3rd. Finally, Leerink Partnrs reissued a market perform rating on shares of Walgreens Boots Alliance in a report on Monday, February 26th. Four investment analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of Hold and a consensus price target of $23.07.

Walgreens Boots Alliance Stock Down 0.3 %

Shares of WBA stock opened at $15.66 on Monday. The stock’s 50 day simple moving average is $16.76 and its 200 day simple moving average is $20.36. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.32 and a current ratio of 0.66. Walgreens Boots Alliance has a twelve month low of $14.62 and a twelve month high of $31.32. The company has a market capitalization of $13.51 billion, a price-to-earnings ratio of -2.24, a PEG ratio of 0.98 and a beta of 0.78.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.82 by $0.38. The firm had revenue of $37.05 billion for the quarter, compared to analyst estimates of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The company’s revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the firm posted $1.16 EPS. As a group, research analysts predict that Walgreens Boots Alliance will post 3.21 EPS for the current year.

Walgreens Boots Alliance Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, June 12th. Shareholders of record on Tuesday, May 21st were paid a $0.25 dividend. The ex-dividend date of this dividend was Monday, May 20th. This represents a $1.00 dividend on an annualized basis and a yield of 6.39%. Walgreens Boots Alliance’s payout ratio is -14.29%.

Insider Buying and Selling at Walgreens Boots Alliance

In other news, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In other news, CFO Manmohan Mahajan acquired 6,000 shares of Walgreens Boots Alliance stock in a transaction dated Tuesday, April 2nd. The stock was bought at an average cost of $19.38 per share, with a total value of $116,280.00. Following the completion of the transaction, the chief financial officer now directly owns 166,969 shares of the company’s stock, valued at $3,235,859.22. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Inderpal S. Bhandari acquired 3,000 shares of Walgreens Boots Alliance stock in a transaction dated Thursday, April 11th. The shares were purchased at an average cost of $18.05 per share, with a total value of $54,150.00. Following the completion of the transaction, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The disclosure for this purchase can be found here. Insiders own 17.40% of the company’s stock.

Institutional Trading of Walgreens Boots Alliance

Several institutional investors and hedge funds have recently bought and sold shares of WBA. Dark Forest Capital Management LP raised its holdings in Walgreens Boots Alliance by 6.5% during the third quarter. Dark Forest Capital Management LP now owns 29,409 shares of the pharmacy operator’s stock worth $654,000 after acquiring an additional 1,804 shares in the last quarter. Cary Street Partners Investment Advisory LLC raised its stake in Walgreens Boots Alliance by 21.6% in the third quarter. Cary Street Partners Investment Advisory LLC now owns 23,417 shares of the pharmacy operator’s stock valued at $521,000 after buying an additional 4,166 shares during the period. Connor Clark & Lunn Investment Management Ltd. bought a new stake in Walgreens Boots Alliance in the third quarter valued at approximately $5,494,000. Natixis Advisors L.P. raised its stake in Walgreens Boots Alliance by 268.4% in the third quarter. Natixis Advisors L.P. now owns 184,722 shares of the pharmacy operator’s stock valued at $4,108,000 after buying an additional 134,587 shares during the period. Finally, Parkside Financial Bank & Trust raised its stake in Walgreens Boots Alliance by 30.5% in the third quarter. Parkside Financial Bank & Trust now owns 3,579 shares of the pharmacy operator’s stock valued at $80,000 after buying an additional 837 shares during the period. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.